131Iodine-GD2-ch14.18 scintigraphy to evaluate option for radioimmunotherapy in patients with advanced tumors

Rupert Handgretinger

Rupert Handgretinger

¹³¹Iodine-GD2-ch14.18 scintigraphy to evaluate option for radioimmunotherapy in patients with advanced tumors

Ying Zhang, Juergen Kupferschlaeger, Peter Lang, Gerald Reischl, Rupert J. Handgretinger, Christian la Fougère, Helmut Dittmann

Journal of Nuclear Medicine
published on May 28, 2021
doi:10.2967/jnumed.120.261854

131Iodine-GD2-ch1418-scintigraphy-to-evaluate-option-for-radioimmunotherapy-RH

More publications from Rupert Handgretinger

Removal of CD276+ cells from haploidentical memory T-cell grafts significantly lowers the risk of GVHD

Bernd Landmann2021-11-06T07:41:22+01:00Categories: Other article for therapists|Tags: Rupert Handgretinger|

New immune therapies combined with complementary-oncology measures… together, we are stronger!

Bernd Landmann2021-11-05T20:29:09+01:00Categories: Other article for therapists|Tags: Rupert Handgretinger|

Immunomonitoring of Stage IV Relapsed Neuroblastoma Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation

Bernd Landmann2021-11-06T08:12:49+01:00Categories: Other article for therapists|Tags: Rupert Handgretinger|

131Iodine-GD2-ch14.18 scintigraphy to evaluate option for radioimmunotherapy in patients with advanced tumors

Bernd Landmann2021-11-06T08:20:06+01:00Categories: Other article for therapists|Tags: Rupert Handgretinger|

Bernd Landmann2021-11-06T08:20:06+01:00November 6, 2021|Other article for therapists|